Denmark’s medical cannabis industry secures major investment

Cannabis cultivator Atlas Biotechnologies is the latest Canadian firm to establish a base in Denmark where a medical cannabis trial is thriving.

Atlas follows in the footsteps of Canada-based international producers Aphria, ICC International Cannabis, Aurora Cannabis, Canopy Growth and The Green Organic Dutchman. Atlas Growers Denmark has leased a 170,000 sq. ft. indoor mushroom farm for conversion into cannabis production facility.


We finally know the biological reason marijuana might impact sperm quality

Marijuana and sperm have a complicated and confusing relationship. Some studies have found that men who smoke marijuana have a higher sperm count. Other research has found they have a lower sperm count. Regardless, what’s decided is that the hundreds of chemicals in marijuana tinker with sperm on a deep level — and new research demonstrates why.


The Danish medical cannabis industry – six months on

The future looks bright for the Danish medical cannabis industry, but speaking to Rikke Jakobsen, CEO of Cannabis Denmark, there is still work to be done.

The Danish medical cannabis industry is a dynamically evolving world, with this in mind, Health Europa spoke with Rikke Jakobsen, CEO of Cannabis Denmark in late 2018 to discuss the pioneering medical cannabis pilot and development programmes the country had recently launched, along with the impact this was set to have on patients, growers and healthcare professionals.


The Danish medical cannabis pilot programme: putting the patient first

With the Danish medical cannabis pilot scheme now well underway, then Minister for Health Ellen Trane Nørby, talks her vision for the programme.

Ellen Trane Nørby in her capacity as Minister of Health oversaw the implementation of the landmark medical cannabis pilot scheme in Denmark. Addressing attendees at the MJBiz Daily European Cannabis Symposium in Copenhagen, she made a passionate case for allowing vulnerable patients access to the treatment and recalled some of the patients she has met along the way.


Copenhagen police are not happy about people driving scooters under the influence

Danish police have started cracking down on a particular crowd of impaired drivers—those who are a little too drunk or high to be riding a scooter, writes Calvin Hughes.


Five ways to play the emerging global cannabis industry, from Colombia to Denmark

Since recreational cannabis was legalized in Canada in October 2018, most investors looking to catch a ride on the green wave, bumpy as it may be, have focussed on the opportunities available at home and in the United States. But while Canada may have taken the biggest leap into the legal realm, it is not the only country in which attitudes toward cannabis are changing. Here’s a look at five internationally focussed stocks that investors can look to for exposure to the emerging global cannabis industry.


Discover the barriers of accessing medical cannabis despite reform across Europe

Although regulatory reform has occurred across Europe, many patients still experience barriers regarding accessing medical cannabis, here Prohibition Partners explores further.

Prohibition Partners explains how legislation intended to improve availability of accessing medical cannabis for patients is being hindered by a lack of education in clinicians and regulators.


Aurora, Canopy and Spectrum among names waiting for Danish licences

Five companies have applied to Denmark’s government for licenses to sell and export medicinal cannabis.

The country is a quarter of the way through a four-year medicinal cannabis trial, but some of the usual suspects are not waiting for the outcome to slow down their Danish strategy in what is emerging as a key market.

Aurora Nordic, Medican, Medical Cannabis Denmark, Schroll Medical/Aphria, and Spectrum Cannabis Denmark (part of Canopy Growth) are hoping to gain approval for bulk manufacturing licenses.

Denmark is not a European Union state, but is part of the European Economic Area and firms situated there can export to the bloc, which with a population of 700m has the potential to be the world’s largest market, according to cannabis intelligence researchers.


A detailed look at how Aurora Cannabis can produce 700,000 kilograms a year

The marijuana industry is growing like a weed. According to various Wall Street prognostications, the global cannabis industry could be generating upwards of $50 billion to $75 billion in annual sales roughly one decade from now. That's a boatload of cash, and all the more reason for pot growers to double down on capacity expansion.

Although there are 11 growers that are currently on pace for more than 100,000 kilograms in peak annual output, according to their respective management teams, none stands out more than Alberta-based Aurora Cannabis (NYSE:ACB).


Indiva enters into agreement to acquire license in Denmark and creates gateway to European market

Indiva will have the exclusive right to all cannabis-related production. Subject to applicable regulatory approvals, Indiva will also leverage the Denmark license for the importation of EU-GMP cannabis into the Danish and European markets.


Indiva has identified Europe as a key emerging market in cannabis, estimated at some $80 -100 billion at maturity1. Europe is home to greater than 500 million people and the growing acceptance of medical cannabis is leading to significant growth in registered patients.


Subscribe to RSS - Denmark